Understanding and overcoming vaccine hesitancy in Latin America: A descriptive and experimental study

How to cite

Marshall, John; Pocasangre, Oscar; Gerez, Julian; Daly, Sarah; Barham, Elena; Argote, Pablo. 2021. "Understanding and overcoming vaccine hesitancy in Latin America: A descriptive and experimental study." AEA RCT Registry. AEARCTR-0007080. https://doi.org/10.1257/rct.7080-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

John Marshall* , Oscar Pocasangre , Julian Gerez , Sarah Daly , Elena Barham , Pablo Argote

* Primary investigator

Registry ID
AEARCTR-0007080
DOI
https://doi.org/10.1257/rct.7080-1.0
First registered
Last updated
Status
On going
Trial dates
2021-01-11 – 2021-01-29
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/7080

Abstract

COVID-19 has had wide-reaching health and economic consequences across Latin America. Governments throughout the region have begun to distribute approved vaccines to combat its spread. However, absent willingness by citizens to receive these vaccines, vaccination efforts could be seriously hampered. This study first aims to provide descriptive characteristics of vaccine hesitancy in the region. Among the hesitant, we then seek to understand how levels of hesitancy are affected by information relating to health, social, political, and vaccine-specific factors. We thereby aim to identify how governments can frame vaccination campaigns to maximize vaccine uptake. Using an online survey of thousands of respondents across six Latin American countries---Argentina, Brazil, Chile, Colombia, Mexico, and Peru---we randomize (i) the type of public health information that respondents receive about COVID-19 and (ii) different motivations for getting vaccinated, as well as conduct a conjoint experiment to identify the different features of hypothetical, but plausible, vaccine distribution scenarios that may influence vaccine uptake. The findings will inform the scope and contours of vaccine hesitancy in the context of COVID-19 and the efficacy of vaccination campaign strategies.

Intervention

This study seeks to understand and remedy the informational, social, and political bases of COVID-19 vaccine hesitancy. To do so, we experimentally test differences in the effects of public health and motivational information interventions. As part of a survey, we randomly assign respondents to receive one of the following types of public health information:
---control
---basic health information (what vaccines do, approval of COVID-19 vaccines, safety and efficaciousness of vaccines)
---basic health information + herd immunity (the share of the population needs to be vaccinated to achieve herd immunity, which is randomly varied between 60, 70, 80%)
---basic health information + herd immunity + current willingness (the share of the population that is currently willing to be vaccinated)
---basic health information + Biden (information explaining that US President Biden recently got vaccinated).

We then cross-randomize this public health information with the following motivational treatments:
---control
---motivation priming the altruistic benefits of getting vaccinated
---motivation priming the social status associated with getting vaccinated
---motivation priming the importance of vaccination for economic recovery

In addition to the informational treatments just described, we further conduct a conjoint experiment that randomly varies features of hypothetical vaccine scenarios.

Experimental design

The treatments are randomized within Qualtrics, blocked at the country x baseline hesitancy x age group level. The information is received around halfway through the experiment, and outcomes are measured after treatment.

Design details

Randomization method
Block randomization within Qualtrics.
Randomization unit
Information treatments will be randomized at the individual level.
Clusters
Around 6,000 hesitant individual will complete the survey, with around 1,000 from each country.
Observations
For most outcomes, we will observe outcomes for all 6,000 individuals. For the conjoint experiments, we will observe 5 outcomes per individual, for a total of around 30,000 outcomes.
Arms
Among the health information treatments: 3/14 control; 3/14 basic health information; 3/14 basic + herd immunity information; 3/14 basic + herd immunity + current willingness information; 2/14 basic + Biden information. Among the cross-randomized motivational information: 1/4 control; 1/4 altruism; 1/4 economic recovery; 1/4 social status.
Primary outcomes
We study three main types of outcome: general willingness to take a COVID-19 vaccine; immediacy of willingness to take a COVID-19 vaccine once available; and a behavioral measure of willingness to receive more information about COVID-19 vaccines.
Secondary outcomes
We will study a variety of potential mechanisms that could be activated by the different informational treatments, including posterior beliefs about others' willingness to vaccinate, concerns about vaccination, prospects for economic recovery, etc.
Sponsors
Name: Columbia University Institute for Social and Economic Research and Policy Location: New York, NY, USA Url: http://iserp.columbia.edu/

Cited by

No citation data available for this registration yet.

Keywords